Safety and efficacy of inclisiran in South African patients at high cardiovascular risk: A subanalysis of the ORION phase III clinical trials
SAMJ: South African Medical Journal, 2022-06, Vol.112 (6), p.426-432 [Peer Reviewed Journal]COPYRIGHT 2022 Health & Medical Publishing Group ;This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. ;ISSN: 0256-9574 ;ISSN: 2078-5135 ;EISSN: 2078-5135 ;DOI: 10.7196/SAMJ.2022.v112i6.16253
Full text available